• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • NMPA and Allergan co-hosted the Webinar: Application of RWD and Fast-track Approval in Hainan Boao Lecheng International Medical Tourism Pilot Zone

NMPA and Allergan co-hosted the Webinar: Application of RWD and Fast-track Approval in Hainan Boao Lecheng International Medical Tourism Pilot Zone

Real-world data Application in China
Friday, 05 June 2020 / Published in Medical Device

NMPA and Allergan co-hosted the Webinar: Application of RWD and Fast-track Approval in Hainan Boao Lecheng International Medical Tourism Pilot Zone

On 13.05.2020, various departments of the NMPA hosted a webinar with a representative from Allergan, the US global pharmaceutical company that was recently acquired by AbbVie Inc, another US company. Allergan’s glaucoma drainage tube was approved by the NMPA on 26.03.2020 to become the first imported medical device utilizing real-world data to register in China.

The webinar topic was real world data research and how to use real world data in registration applications.

The authorities and persons involved were: Mrs. Xuan HE (China Pharmaceutical News), Mrs. Hong LU (reviewer from CMDE), Mrs. Ning ZHU (Vice Director of Hainan MPA), Prof. Xin SUN (Director of The Chinese Cochrane Center), Mr. Lipeng WAN (RA Director, Allergan Shanghai), and Mr. Jun XU (China Health Media Group).

Apart from sharing their views on the application and transformation of real-world data in China, some clarifications were provided about the latest definitions of real-world data, real-world study/research, and real-world evidence applicable in China:

RWD (Real-world data) refers to the data derived from health care settings and sources other than traditional clinical trials to reflect the patients’ health status and the delivery of health care.

RWS/RWR (Real-world study/research) refers to the study and research of RWD on scientific topics and the comprehensive use of medical methods from epidemiology, biostatistics, evidence-based medicine, etc.

RWE (Real-world evidence) refers to the clinical evidence regarding the usage and potential risks / benefits of a medical product derived from the analysis of RWD.

During the registration process of Allergan’s glaucoma drainage tube, the NMPA also utilized the real-world data collected in Hainan’s Boao Lecheng International Medical Tourism Pilot Zone to evaluate ethnic diversity among patients.

Mr. Wan of Allergan Shanghai was asked about his registration experience using real-world data but declined to provide any details about the registration, other than that communication is important and their team is hardworking.

We have separately reported about the sharp increase in products applying to enter the Hainan Pilot Zone.

By Jacky Li. Contact Cisema to learn more.

Tagged under: Hainan Boao Lecheng International Medical Tourism Pilot Zone, Real-world data, Real-world evidence, Real-world research, Real-world study, RWD, RWE, RWR, RWS

What you can read next

Clinical evaluation of ventilators
Clinical evaluation of ventilators – Technical review guidelines issued by China NMPA
China SAMR 3 Stipulation Scheme Unveiled
Technical Review Guidance Draft for the NMPA Registration of Citric Acid Disinfectants

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Children cosmetics technical guidelines in China

    Children cosmetics technical guidelines in China – Newly issued by NIFDC

    Children cosmetics technical guidelines in Chin...
  • pH Determination Method

    China’s cosmetic safety technical specifications – 21 revision items issued

    China’s cosmetic safety technical specifi...
  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...
  • China Medical Device Webinar

    China Medical Device Webinar with AdvaMed Accel for U.S. exporters

    The China Medical Device Webinar will be featur...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2003-2023 Cisema. All rights reserved.

TOP